0000899243-21-016871.txt : 20210423 0000899243-21-016871.hdr.sgml : 20210423 20210423165130 ACCESSION NUMBER: 0000899243-21-016871 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210415 FILED AS OF DATE: 20210423 DATE AS OF CHANGE: 20210423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hashemi Hutan CENTRAL INDEX KEY: 0001849054 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39334 FILM NUMBER: 21850485 MAIL ADDRESS: STREET 1: 4330 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92122 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENITY, INC. CENTRAL INDEX KEY: 0001580063 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 273950390 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4330 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 855-293-2639 MAIL ADDRESS: STREET 1: 4330 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: ASCENDANT MDX, INC. DATE OF NAME CHANGE: 20130625 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-04-15 2021-04-19 0 0001580063 PROGENITY, INC. PROG 0001849054 Hashemi Hutan C/O PROGENITY, INC. 4330 LA JOLLA VILLAGE DRIVE, SUITE 200 SAN DIEGO CA 92122 0 1 0 0 Chief Compliance Officer Common Stock 2021-04-15 4 A 0 11494 0.00 A 22667 D Stock Option (Right to Buy) 3.41 2021-04-15 4 A 0 24114 0.00 A 2031-04-15 Common Stock 24114 24114 D Consists of 11,494 restricted stock units, 25% of which will vest on May 15, 2022, with the remaining shares vesting in equal semi-annual installments through May 15, 2025, subject to the Reporting Person's continued service to the Issuer. The Reporting Person's Form 4 filed on April 19, 2021 inadvertently omitted from the total amount of securities beneficially owned following the transaction 11,173 shares previously reported on the Reporting Person's Form 3 filed on March 15, 2021. This option represents the right to purchase 24,114 shares of the Issuer's common stock, 502 of which vested upon grant, with the remaining shares vesting in equal monthly installments through March 15, 2025, subject to the Reporting Person's continued service to the Issuer. /s/ Will Pridgen, Attorney-in-Fact for Hutan Hashemi 2021-04-23